Literature DB >> 24065545

Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.

Helena Rudnicka1, Tadeusz Debniak, Cezary Cybulski, Tomasz Huzarski, Jacek Gronwald, Jan Lubinski, Bohdan Gorski.   

Abstract

BRCA1 and BRCA2 are two major genes associated with familial breast and ovarian cancer susceptibility. In Poland standard BRCA gene test is usually limited to Polish founder BRCA1 mutations: 5382insC, C61G and 4153delA. To date, just a few single large genomic rearrangements (LGRs) of BRCA1 gene have been reported in Poland. Here we report the first comprehensive analysis of large mutations in BRCA1 and BRCA2 genes in this country. We screened LGRs in BRCA1 and BRCA2 genes by multiplex ligation-dependent probe amplification in 200 unrelated patients with strong family history of breast/ovarian cancers and negative for BRCA1 Polish founder mutations. We identified three different LGRs in BRCA1 gene: exons 13-19 deletion, exon 17 deletion and exon 22 deletion. No LGR was detected in BRCA2 genes. Overall, large rearrangements accounted for 3.7 % of all BRCA1 mutation positive families in our population and 1.5 % in high-risk families negative for Polish founder mutation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065545     DOI: 10.1007/s11033-013-2775-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.

Authors:  A Jakubowska; B Górski; T Byrski; T Huzarski; J Gronwald; J Menkiszak; C Cybulski; T Debniak; P Hadaczek; R J Scott; J Lubinski
Journal:  Hum Mutat       Date:  2001-08       Impact factor: 4.878

2.  Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.

Authors:  J Lahti-Domenici; K Rapakko; K Pääkkönen; M Allinen; H Nevanlinna; M Kujala; P Huusko; R Winqvist
Journal:  Cancer Genet Cytogenet       Date:  2001-09

3.  Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.

Authors:  Sara Gutiérrez-Enríquez; Miguel de la Hoya; Cristina Martínez-Bouzas; Ana Sanchez de Abajo; Teresa Ramón y Cajal; Gemma Llort; Ignacio Blanco; Elena Beristain; Eduardo Díaz-Rubio; Carmen Alonso; María-Isabel Tejada; Trinidad Caldés; Orland Diez
Journal:  Breast Cancer Res Treat       Date:  2006-10-25       Impact factor: 4.872

4.  Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families.

Authors:  A M Woodward; T A Davis; A G S Silva; J A Kirk; J A Leary
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

5.  Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.

Authors:  Zsofia K Stadler; Emmanuel Saloustros; Nichole A L Hansen; Alice E Schluger; Noah D Kauff; Kenneth Offit; Mark E Robson
Journal:  Breast Cancer Res Treat       Date:  2010-03-11       Impact factor: 4.872

6.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701

7.  The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.

Authors:  Ana Peixoto; Catarina Santos; Patrícia Rocha; Manuela Pinheiro; Sofia Príncipe; Deolinda Pereira; Helena Rodrigues; Fernando Castro; Joaquim Abreu; Leonor Gusmão; António Amorim; Manuel R Teixeira
Journal:  Breast Cancer Res Treat       Date:  2008-03-25       Impact factor: 4.872

8.  Significant contribution of germline BRCA2 rearrangements in male breast cancer families.

Authors:  Isabelle Tournier; Brigitte Bressac-de Paillerets; Hagay Sobol; Dominique Stoppa-Lyonnet; Rosette Lidereau; Michel Barrois; Sylvie Mazoyer; Florence Coulet; Agnès Hardouin; Agnès Chompret; Alain Lortholary; Pierre Chappuis; Violaine Bourdon; Valérie Bonadona; Christine Maugard; Brigitte Gilbert; Catherine Nogues; Thierry Frébourg; Mario Tosi
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

9.  Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.

Authors:  T Peelen; M van Vliet; A Bosch; G Bignell; H F Vasen; J G Klijn; H Meijers-Heijboer; M Stratton; G J van Ommen; C J Cornelisse; P Devilee
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

10.  High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.

Authors:  Petra Vasickova; Eva Machackova; Miroslava Lukesova; Jiri Damborsky; Ondrej Horky; Hana Pavlu; Jitka Kuklova; Veronika Kosinova; Marie Navratilova; Lenka Foretova
Journal:  BMC Med Genet       Date:  2007-06-11       Impact factor: 2.103

View more
  9 in total

1.  Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing.

Authors:  Magdalena Ratajska; Magdalena Krygier; Maciej Stukan; Alina Kuźniacka; Magdalena Koczkowska; Mirosław Dudziak; Marcin Śniadecki; Jarosław Dębniak; Dariusz Wydra; Izabela Brozek; Wojciech Biernat; Ake Borg; Janusz Limon; Bartosz Wasąg
Journal:  J Appl Genet       Date:  2014-11-01       Impact factor: 3.240

2.  BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.

Authors:  Ingrid Petroni Ewald; Silvia Liliana Cossio; Edenir Inez Palmero; Manuela Pinheiro; Ivana Lucia de Oliveira Nascimento; Taisa Manuela Bonfim Machado; Kiyoko Abe Sandes; Betânia Toralles; Bernardo Garicochea; Patricia Izetti; Maria Luiza Saraiva Pereira; Hugo Bock; Fernando Regla Vargas; Miguel Ângelo Martins Moreira; Ana Peixoto; Manuel R Teixeira; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2016 Apr-Jun       Impact factor: 1.771

3.  Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.

Authors:  Boyoung Park; Ji Yeon Sohn; Kyong-Ah Yoon; Keun Seok Lee; Eun Hae Cho; Myong Cheol Lim; Moon Jung Yang; Soo Jin Park; Moo Hyun Lee; See Youn Lee; Yoon Jung Chang; Dong Ock Lee; Sun-Young Kong; Eun Sook Lee
Journal:  Breast Cancer Res Treat       Date:  2017-02-15       Impact factor: 4.872

4.  Genomic rearrangement screening of the BRCA1 from seventy Iranian high-risk breast cancer families.

Authors:  Maryam Sedghi; Elham Esfandiari; Esmat Fazel-Najafabadi; Mansoor Salehi; Abbas Salavaty; Shirin Fattahpour; Leila Dehghani; Nayerossadat Nouri; Fariborz Mokarian
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

5.  Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center.

Authors:  Anikó Bozsik; Tímea Pócza; János Papp; Tibor Vaszkó; Henriett Butz; Attila Patócs; Edit Oláh
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

6.  BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.

Authors:  Ewelina Szczerba; Katarzyna Kamińska; Tomasz Mierzwa; Marcin Misiek; Janusz Kowalewski; Marzena Anna Lewandowska
Journal:  Genes (Basel)       Date:  2021-04-02       Impact factor: 4.096

Review 7.  New challenges for BRCA testing: a view from the diagnostic laboratory.

Authors:  Andrew J Wallace
Journal:  Eur J Hum Genet       Date:  2016-09       Impact factor: 4.246

Review 8.  Germline Structural Variations in Cancer Predisposition Genes.

Authors:  Tímea Pócza; Vince Kornél Grolmusz; János Papp; Henriett Butz; Attila Patócs; Anikó Bozsik
Journal:  Front Genet       Date:  2021-04-14       Impact factor: 4.599

9.  Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.

Authors:  Yi-Ping Hung; Chia-Jen Liu; Yu-Wen Hu; Min-Huang Chen; Chun-Pin Li; Chiu-Mei Yeh; Tzeon-Jye Chiou; Tzeng-Ji Chen; Muh-Hwa Yang; Yee Chao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.